O-glycan recognition and function in mice and human cancers

Area of Science:

• Biochemistry
• Glycobiology
• Oncology

Background:

• Protein glycosylation, a common post-translational modification, has significant pathological consequences when altered.
• O-glycosylation, the attachment of N-acetylgalactosamine (GalNAc) to serine/threonine residues, produces diverse oligosaccharides crucial for cell function.
• Tumor cells exhibit distinct O-glycan profiles compared to normal cells, making them key areas of research.

Purpose of the Study:

• To explore O-glycosylation in murine and human tumor cells, focusing on colorectal, breast, and pancreatic cancers.
• To detail the structure, function, and recognition of O-glycans in the context of cancer.
• To highlight the potential of O-glycosylation knowledge for developing novel cancer diagnostics and therapeutics.

Main Methods:

• Review of existing literature on O-glycosylation in cancer.
• Analysis of O-glycan structures and their expression patterns in various tumor types.
• Examination of the role of O-glycans as tumor-associated carbohydrate antigens (TACAs).

Main Results:

• Tumor cells characteristically display altered O-glycan structures, both quantitatively and qualitatively.
• Specific O-glycans, such as Tn antigen and sialyl-Tn antigen (STn), are prevalent in carcinomas and contribute to tumor progression.
• Altered O-glycans function as valuable circulating tumor biomarkers (e.g., CA19-9, CA-125) and immunohistochemical markers.

Conclusions:

• O-glycosylation patterns are significantly dysregulated in cancer cells.
• Tumor-associated O-glycans offer promising targets for cancer diagnosis and staging.
• Exploiting the understanding of tumor O-glycosylation presents substantial opportunities for advancing cancer treatment strategies.